Acquisition of the approval for marketing the Novel Coronavirus (SARS-CoV-2) Detection Reagent Kit as an In Vitro Diagnostic Product September 17, 2020September 17, 2020 by / Share This.....LinkedinTwitterFacebookGoogleEmailAcquisition of the approval for marketing the Novel Coronavirus (SARS-CoV-2) Detection Reagent Kit as an In Vitro Diagnostic Product Related News: PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2…Thermo Fisher Scientific Launches Ion AmpliSeq…PerkinElmer Completes Acquisition of Antibody and…Contributing to PCR Screening Tests for Mutant…Thermo Fisher Scientific Launches Wastewater…PacBio Launches HiFiViral SARS-CoV-2 Kit and…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
